CollPlant Biotechnologies (CLGN) Cost of Revenue (2017 - 2026)
CollPlant Biotechnologies (CLGN) reported Cost of Revenue of $564,000 for the quarter ended Jun 30, 2026, up 203.2% from $186,000 a year earlier and up 78.5% from the prior quarter.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Cost of Revenue (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CollPlant Biotechnologies' Cost of Revenue came in at $1.34 million, up 46.1% year-over-year; for the year ended Dec 31, 2025, it came in at $835,000, down 48.6% from the prior year.
- Cost of Revenue has a five-year compound annual growth rate of -22.6% (years ended Dec 2020 to Dec 2025).
- By year, Cost of Revenue came in at $1.63 million in the year ended Dec 31, 2024 (-18.4%), $1.99 million in the year ended Dec 31, 2023 (+397.8%), $400,000 in the year ended Dec 31, 2022 (-80.0%) and $2.01 million in the year ended Dec 31, 2021 (-33.2%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Cost of Revenue since the quarter ended Dec 31, 2023.
- Year over year, Cost of Revenue gained in two of the last eight quarters, with growth averaging 5.4%.
- The high point for year-over-year Cost of Revenue in five years was the quarter ended Mar 31, 2023 (growth of 948.4%); the low point was the quarter ended Mar 31, 2022 (a decline of 96.5%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $316,000 (quarter ended Mar 30, 2026), $192,000 (quarter ended Dec 31, 2025) and $269,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | CollPlant Biotechnologies | 4.38 Mn | -25.06 Mn | -456,000.00 | 564,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 564,000.00 |
| Mar 30, 2026 | 316,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 30, 2025 | 188,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | 545,000.00 |
| Dec 31, 2023 | 773,000.00 |
| Sep 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 615,000.00 |
| Mar 31, 2023 | 325,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 43,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 142,000.00 |
API Access
CollPlant Biotechnologies Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();